Casa
fierce pharma

Fierce Pharma: Pharma has a real-world problem, and it's the lag in it

Por um escritor misterioso

Descrição
Adoption of mobile and connected health tech in clinical trials is a real-world challenge for pharmaceutical companies. Our CEO Pierre-Alexandre Fournier has shared his thoughts recently about the adoption of mobile and connected health tech with Fierce Pharma. "The industry needs to get with it now or pay for it later
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
Fierce Pharma awards best-in-class marketing campaigns
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
The most influential people in biopharma today
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
The New Humanitarian Trends driving humanitarian crises in 2023
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
The Lucky Years: How to Thrive in by Agus, David B.
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
When Evidence Says No, But Doctors Say Yes — ProPublica
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
Drug shortages: what is causing immune globulin access issues?
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
If pharma looks slow to adopt AI, it's got good reason, expert
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
MARKET REPORT - Survey Suggests Global Innovation to Recover Much
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
Biopharma digital transformation
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
The Lucky Years: How to Thrive in by Agus, David B.
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
2022's Fiercest Women in Life Sciences
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
Pfizer adds Coca-Cola, GE vets to board to help navigate post
Fierce Pharma: Pharma has a real-world problem, and it's the lag in it
Lessons From the Rise and Fall of Japan's Life-Sciences Innovation
de por adulto (o preço varia de acordo com o tamanho do grupo)